세계의 뇌 모니터링 디바이스 시장 규모는 2023년에 63억 1,000만 달러, 2030년까지 96억 1,000만 달러에 달하며, 2024-2030년의 예측 기간에 CAGR로 7.27%의 성장이 전망됩니다. 뇌 모니터링 디바이스에 대한 수요는 주로 신경 질환의 유병률 증가, 제품 개발의 기술 발전, 신경 퇴행성 질환에 대한 인식 증가, 임상시험에서 뇌 모니터링의 사용 증가에 의해 주도되고 있습니다. 저침습적 장비에 대한 수요 증가와 뇌 모니터링 디바이스의 치료 적용 확대는 뇌 모니터링 디바이스 시장의 성장을 더욱 촉진할 것으로 예상됩니다.
뇌 모니터링 디바이스 시장 역학
세계보건기구(WHO)가 2023년 발표한 자료에 따르면 전 세계에서 약 5,000만 명이 간질을 앓고 있으며, 2019년 세계에서 가장 흔한 신경질환 중 하나입니다. 간질 환자의 약 80%가 중저소득 국가에 거주하고 있습니다. 또한 적절한 진단과 치료를 받으면 간질 환자의 최대 70%가 발작 없이 생활할 수 있을 것으로 예측됩니다.
WHO가 2023년 발표한 자료에 따르면 약 5,500만 명이 치매를 앓고 있으며, 매년 1,000만 명에 가까운 사람들이 새로 발병하고 있습니다. 알츠하이머병은 가장 흔한 치매로 전체 치매 환자의 60-70%를 차지합니다.
Alzheimer Europe(2019)에 따르면 2050년까지 치매 환자 수는 EU에서 1,429만 8,671명, 유럽 전체에서 1,884만 6,286명으로 증가할 것으로 추산됩니다.
상기와 같은 신경 질환 증가는 치료 요법의 성공 여부를 모니터링하는 것과 함께 질환의 진행을 모니터링하는 데 사용되는 장비에 대한 더 큰 요구를 가져올 수 있습니다. 따라서 뇌 모니터링 기기에 대한 수요는 예측 기간 중 증가할 것으로 예상됩니다.
그러나 신흥 경제국에서는 필요한 의료 인프라가 제대로 갖춰져 있지 않고, 제품 및 시술에 대한 안전 문제가 뇌 모니터링 디바이스 시장의 성장을 저해하는 요인으로 작용할 수 있습니다.
뇌 모니터링 디바이스 시장 부문별 분석
뇌 모니터링 디바이스 시장의 제품 유형 부문에서는 뇌파 장비 부문이 예측 기간 중 가장 큰 시장 점유율을 차지할 것으로 예상됩니다. 이는 다양한 신경 질환의 치료에서 뇌파 장비와 관련된 장점과 용도에 기인합니다.
EEG 장비는 뇌 활동을 실시간으로 기록하기 때문에 간질 및 기타 발작성 질환을 포함한 신경 질환을 진단하는 데 매우 중요합니다. 간질 발작 사이의 환자를 모니터링하거나 발작을 예측하고 제어하는 데 도움이 됩니다.
뇌파계는 수면장애를 연구하는 데도 사용되며, 수면의 이상 여부를 파악하는 데도 사용됩니다. 불면증 및 기타 스트레스 관련 장애를 포함한 수면장애의 유무와 심각성을 감지하는 데 도움이 될 수 있습니다. 뇌파 검사 중 수면은 뇌의 활동을 종합적으로 평가할 수 있습니다.
뇌파 검사는 환자가 뇌사 또는 혼수상태에 빠졌을 때 뇌사 또는 혼수상태로 진단해야 할 경우, 이를 지원하는 증거로 사용되기도 합니다.
장시간 뇌파 검사가 가능한 무선 뇌파 시스템 출시와 같은 기술 발전도 의료 서비스 프로바이더들 사이에서 이러한 기기의 인기를 높이는 데 한몫을 하고 있습니다.
예를 들어 Masimo의 SedLine은 FDA 승인을 받은 뇌 기능 모니터링 장비로, 임상의가 마취 상태에서 뇌 상태를 모니터링할 수 있도록 도와줍니다.
따라서 끊임없는 기술 발전과 뇌파 장비의 응용 범위 확대는 뇌 모니터링 디바이스 시장의 다른 제품 유형 중에서도 뇌파 장비에 대한 전망을 밝게 하고 있습니다.
북미가 전체 뇌 모니터링 디바이스 시장을 독점할 것으로 예상됩니다.
모든 지역 중 북미가 뇌 모니터링 디바이스 시장에서 가장 큰 점유율을 차지할 것으로 예상됩니다. 신경 질환의 유병률 증가, 우수한 의료 인프라에 대한 접근성, 이 지역의 주요 시장 기업의 존재는 예측 기간 중 전체 시장의 성장을 가속하는 주요 요인이 될 것으로 예상됩니다.
세계의 뇌 모니터링 디바이스 시장에 대해 조사분석했으며, 시장 규모와 예측, 촉진요인과 과제, 기업과 제품 개요 등을 제공하고 있습니다.
Brain Monitoring Devices Market By Product Type (Electroencephalography (EEG) Devices, Magnetoencephalography (MEG) Devices, Electromyography (EMG) Devices, Transcranial Doppler, Intracranial Pressure Monitoring Devices, and Others), Device Type (Invasive and Non Invasive), Application (Epilepsy, Parkinson's Disease, Alzheimer's Disease, Strokes, and Others), End-User (Hospitals, Diagnostic Centers, and Others), and Geography is expected to grow at a steady CAGR forecast till 2030 owing to increasing prevalence of neurological diseases and rising application of brain monitoring in clinical trials
Global Brain Monitoring Devices Market was valued at USD 6.31 billion in 2023, growing at a CAGR of 7.27% during the forecast period from 2024 to 2030, to reach USD 9.61 billion by 2030. The demand for brain monitoring devices is primarily being boosted by the rising prevalence of neurological diseases, technological advancement in product development, rising awareness about neurodegenerative diseases, and increasing applications of brain monitoring in clinical trials. The growing demand for minimally invasive devices and the expanded therapeutic applications of brain monitoring devices are further expected to boost the brain monitoring devices market growth.
Brain Monitoring Devices Market Dynamics:
According to the data provided by the World Health Organization (WHO) 2023, approximately 50 million people across the globe were suffering from epilepsy, making it one of the most common neurological diseases globally in 2019. About 80% of people with epilepsy live in low- and middle-income countries. Furthermore, it is predicted that up to 70% of people living with epilepsy could live seizure-free if properly diagnosed and treated.
As per the data provided by WHO 2023, about 55 million people are living with dementia, and there are nearly 10 million new cases every year. Alzheimer's disease is the commonest form of dementia and contributes to 60-70% of cases.
According to Alzheimer Europe 2019, it has been estimated that by 2050 the number of people with dementia will increase to 14,298,671 in the EU and 18,846,286 in the wider European region.
The rising number of neurological diseases such as those mentioned above would result in the greater requirement for devices used in monitoring disease progression along with the monitoring of treatment regimens being successful or not. Therefore, the demand for brain monitoring devices is expected to witness an increase in the forecast period.
However, the non-availability of the required healthcare infrastructure in developing economies, and safety concerns regarding products and procedures may prove to be certain restraints to the brain monitoring devices market growth.
Brain Monitoring Devices Market Segment Analysis:
Brain Monitoring Devices by Product Type (Electroencephalography (EEG) Devices, Magnetoencephalography (MEG) Devices, Electromyography (EMG) Devices, Transcranial Doppler, Intracranial Pressure Monitoring Devices, and Others), Device Type (Invasive And Non Invasive), Application (Epilepsy, Parkinson's Disease, Alzheimer's Disease, Strokes, and Others), End-User (Hospitals, Diagnostic Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).
In the product type segment of the brain monitoring devices market, the electroencephalography (EEG) devices segment is expected to account for the largest market share during the forecast period. This can be attributed to the advantages and applications associated with EEG devices in the treatment of various neurological diseases.
EEG devices are crucial for the diagnosis of neurological conditions including epilepsy and other seizure disorders as they record brain activity in real time. It assists in the monitoring of patients between epileptic episodes, or to predict and control seizures.
EEG devices are also employed in studying sleep disorders for the identification of any sleep abnormality if present. They help detect the presence and severity of sleep disorders including insomnia and other stress-related disorders. Sleep during an EEG allows for a comprehensive evaluation of brain activity.
EEG studies are also used as supportive evidence in cases where a patient has to be declared brain dead or is in a coma.
Technological advancements such as the launch of wireless EEG systems where long-term EEG studies can be carried out have also contributed to the rising popularity of these devices among healthcare providers.
For example, SedLine by Masimo is FDA cleared brain function monitoring device that helps clinicians monitor the state of the brain under anesthesia, with bilateral acquisition and processing of four leads of electroencephalogram (EEG) signals.
Therefore, the constant technological advancements coupled with the extended application of EEG devices present a positive outlook for EEG devices among other product types in the brain monitoring devices market.
North America is expected to dominate the overall Brain Monitoring Devices Market:
Among all the regions, North America is expected to account for the largest share of the brain monitoring devices market. The growing prevalence of neurological diseases, access to better healthcare infrastructure coupled with the presence of major market players in the region are predicted to be the major influencing factors in driving the overall growth of the market over the forecast period.
As per the data provided by Parkinson's Foundation 2022, about one million people are living with Parkinson's disease (PD) in the US in 2021. This is expected to rise to 1.2 million by 2030. It has been estimated that approximately 60,000 Americans are diagnosed with PD each year. Near bout four percent of people with PD are diagnosed before age 50.
According to the Centers for Disease Prevention and Control (CDC) 2020, there were about 61,000 traumatic brain injury (TBI)-related deaths in the United States in 2019. These statistics point toward the rising number of cases associated with neurological indications.
Considering the presence of a large patient pool in the US coupled with increasing product development activities, the market for brain monitoring devices looks promising in the United States.
For example in August 2020, Masimo received FDA clearance for O3® Regional Oximetry for expanded use in monitoring somatic tissue oxygenation saturation in all patient populations and monitoring relative changes in hemoglobin, oxyhemoglobin, and deoxyhemoglobin in adult patients.
Furthermore, the presence of key players such as Edward Lifesciences Corporation and Medtronic among others and their initiatives to raise awareness on neurological disorders and their management could increase the adoption of brain monitoring devices in the US thus bolstering the market.
Brain Monitoring Devices Market Key Players:
Some of the key market players operating in the brain monitoring devices market include NONIN, Raumedic AG, Masimo, Natus Medical Incorporated, Edwards Lifesciences Corporation, Neurosoft, Advanced Brain Monitoring, Inc, BrainScope Company Inc, Medtronic, NIHON KOHDEN CORPORATION, NeuroWave Systems Inc, Compumedics Limited, Spiegelberg GmbH & Co. KG, Rimed, NOVASIGNAL CORPORATION, and others.
Recent Developmental Activities in Brain Monitoring Devices Market:
In April 2021, Integra LifeSciences Corporation received a 510(k) clearance by the US Food and Drug Administration for CereLink ICP Monitor. This device is intended to be used as an interface between standard physiological pressure monitoring systems and compatible strain-gauge-type pressure transducers.
In March 2021, Brain Scientific Inc received a 510(k) clearance for its next-generation NeuroCap(TM) device. This device is an advanced Electroencephalogram (EEG) electrode array that is employed in routine clinical and research settings to obtain rapid EEGs where STAT EEG recordings are desired.
In February 2020, Compumedics Limited received a 510k clearance from the US FDA for their Orion LifeSpan MEG. This device is equipped to non-invasively measure the magnetoencephalographic (MEG) signals with the option to measure electroencephalographic (EEG) signals as well which are produced by electrically active tissue of the brain.
Key Takeaways from the Brain Monitoring Devices Market Report Study
Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)
The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the brain monitoring devices market.
Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
Key companies dominating the Global Brain Monitoring Devices Market.
Various opportunities available for the other competitor in the Brain Monitoring Devices Market space.
What are the top-performing segments in 2023? How these segments will perform in 2030?
Which are the top-performing regions and countries in the current brain monitoring devices market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for brain monitoring devices market growth in the coming future?
Target Audience who can be benefited from this Brain Monitoring Devices Market Report Study
Brain Monitoring Devices products providers
Research organizations and consulting companies
Brain Monitoring Devices-related organization, association, forum, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and Traders dealing in brain monitoring devices
Various End-users who want to know more about the Brain Monitoring Devices market and the latest technological developments in the Brain Monitoring Devices market.
Frequently Asked Questions for Brain Monitoring Devices Market:
What is a Brain Monitoring Device?
A brain monitoring device helps in the assessment and monitoring of brain function wherein they help in the monitoring of different parameters. EEG, MEG, and functional MRI are a few common brain monitoring devices available in the brain monitoring products market among others.
What is the market for Global Brain Monitoring Devices?
Global Brain Monitoring Devices Market was valued at USD 6.31 billion in 2023, growing at a CAGR of 7.27% during the forecast period from 2024 to 2030, to reach USD 9.61 billion by 2030.
What are the drivers for Global Brain Monitoring Devices Market?
The major drivers of the global brain monitoring devices market growth are the rising prevalence of neurological diseases, growing awareness about neurodegenerative diseases, and the expansion of brain monitoring devices to therapeutic applications among other contributing factors.
What are the key players operating in Global Brain Monitoring Devices Market?
Some of the important market players operating in the brain monitoring devices market include NONIN, Raumedic AG, Masimo, Natus Medical Incorporated, Edwards Lifesciences Corporation, Neurosoft, Advanced Brain Monitoring, Inc, BrainScope Company Inc, Medtronic, NIHON KOHDEN CORPORATION, NeuroWave Systems Inc, Compumedics Limited, Spiegelberg GmbH & Co. KG, Rimed, NOVASIGNAL CORPORATION, and others.
What regions have the highest share in the Brain Monitoring Devices market?
North America is expected to dominate the overall Brain Monitoring Devices market during the forecast period, 2024 to 2030. The high revenue domination across regions by North America can be attributed to the prevalence of neurodegenerative diseases, access to better healthcare infrastructure in the region majorly in the US and Canada along with the presence of major market players in the region. These are expected to be the major influencing factors in driving the overall growth of the brain monitoring devices market over the forecast period.